ADMA, homocysteine and redox status improvement affected by 7-nitroindazole in spontaneously hypertensive rats

• Published in: Biomedicine & pharmacotherapy Vol. 106; pp. 1478 - 1483
• Main Authors: Dovinová, Ima, Hrabárová, Eva, Jansen, Eugene, Kvandová, Miroslava, Majzúnová, Miroslava, Berenyiová, Andrea, Barančík, Miroslav
• Format: Journal Article
• Language: English
• Published: France Elsevier Masson SAS 01.10.2018
• Subjects: 7-Nitroindazole; ADMA; Homocysteine; NOS; Reactive oxygen metabolites; Reactive oxygen species; Redox status; Reactive oxygen species; NOS; Redox status; 7-Nitroindazole; ADMA; Reactive oxygen metabolites; Homocysteine
• ISSN: 0753-3322; 1950-6007
• DOI: 10.1016/j.biopha.2018.07.096

Inhibition of nitric oxide (NO) production can influence blood pressure regulation and increase hypertension. Asymmetric dimethylarginine, ADMA, an analogue of L-arginine, can inhibit NO synthesis, impair endothelial function, and is a risk marker of cardiovascular diseases. Homocysteine (Hcy) level affects oxidative stress production of reactive oxygen species (ROS) in hypertension and also influences changes in signaling and cell damage. The present study was focused on experimental effects of exogenous NOS inhibitors and their effect on ADMA, an endogenous NOS inhibitor, homocysteine and ROS production measured as reactive oxidative metabolites (ROM). We compared effects of the two potential exogenous NO-inhibitors: NG-nitro L-arginine methyl ester (L-NAME) and 7-nitroindazole (7-NI). Levels of ADMA, Hcy, ROM and total thiols (TTL) were not changed in the L-NAME group. With 7-NI administration, we observed unchanged NOS activity in the left ventricle and a pronounced decrease of ADMA and Hcy levels, accompanied by ROM over-production in plasma. TTL/ROM ratio was more favorable than in the L-NAME group. We observed that 7-NI, an exogenous NOinhibitor, can decrease and improve the levels of ADMA, Hcy, and ROM, and increase TTL/ROM ratio in the plasma of spontaneously hypertensive rats.